Underused Weapon in the War on Addiction
January 4, 2018
(Managed Care Magazine) – Buprenorphine is a partial opioid agonist that attaches to the opioid receptors but has a “ceiling effect”—at a moderate dose the effect plateaus and is not increased by taking more. It’s nearly overdose-proof unless combined with other sedating drugs. While it provides a high for the opioid-naïve, it’s a ho-hum experience for individuals with opioid tolerance. All it does is stave off his or her withdrawal symptoms and block opioid craving. That’s why the doctors who believe in it find it a useful tool for putting lives back on track.